Construction and preliminary investigation of a plasmid containing a novel immunotoxin DT390-IL-18 gene for the prevention of murine experimental autoimmune encephalomyelitis

DNA and Cell Biology

Volumn 27, Issue 5, 2008, Pages 279-285

  Jia, Jing ^a   Li, Hong ^a   Tai, Shuhong ^a   Lv, Meili ^a   Liao, Miao ^a   Yang, Zhihui ^a   Zhang, Beilei ^a   Zhou, Bin ^b   Zhang, Gengqian ^a   Zhang, Lin ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; EOSIN; HEMATOXYLIN; IMMUNOTOXIN; IMMUNOTOXIN DT390 IL 18 SRALPHA; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 18 RECEPTOR; LIPOSOME; PHOSPHATE BUFFERED SALINE; PLASMID VECTOR; RECOMBINANT PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; C57BL 6 MOUSE; CELL INFILTRATION; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; DT390 IL 18 GENE; FEMALE; GENE; HINDLIMB; INFLAMMATORY CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANIMALS; DIPHTHERIA TOXIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE THERAPY; IMMUNOTHERAPY; IMMUNOTOXINS; INTERLEUKIN-18; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PLASMIDS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TRANSFECTION;

ANIMALIA; EUKARYOTA; MURINAE; MUS;

EID: 43249123259     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2007.0642     Document Type: Article

References (31)

1. Aktas, O., Waiczies, S., and Zipp, F. (2007). Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets. J Neuroimmunol 184, 17-26.
2. Bauer, J., Rauschka, H., and Lassmann, H. (2001). Inflammation in the nervous system: the human perspective. Glia 36, 235-243.
3. Chen, Y., Langrish, C.L., McKenzie, B., Joyce-Shaikh, B., Stumhofer, J.S., McClanahan, T., Blumenschein, W., Churakovsa, T., Low, J., Presta, L., Hunter, C.A., Kastelein, R.A., and Cua, D.J. (2006). Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 116, 1317-1326.
4. Chen, W., Li, H., Jia, Y., Lv, M., Li, M., Feng, P., Hu, H., and Zhang, L. (2007). In vivo administration of plasmid DNA encoding recombinant immunotoxin DT390-IP-10 attenuates experimental autoimmune encephalomyelitis. J Autoimmun 28, 30-40.
5. Dinarello, C.A. (1999). Interleukin-18. Methods 19, 121-132.
6. Duxbury, M.S., Ito, H., Ashley, S.W., and Whang, E.E. (2004). CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma. Biochem Biophys Res Commun 317, 837-843.
7. Fryxell, D., Li, B.Y., Mohanraj, D., Johnson, B., and Ramakrishnan, S. (1995). Genetic construction of a phosphorylation site in ricin A chain: specific radiolabeling of recombinant proteins for localization and degradation studies. Biochem Biophys Res Commun 210, 253-259.
8. Gutcher, I., Urich, E., Wolter, K., Prinz, M., and Becher, B. (2006). Interleukin 18-independent engagement of interleukin-18 receptor-alpha is required for autoimmune inflammation. Nat Immunol 7, 946-953.
9. Hu, X., Wang, L.F., Lv, P., Gao, X.M. (1999). Expression and analysis of recombinant human IL-18 and human IL-18 GFP fusion protein. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 19, 306-310.
10. Jia, Y., Li, H., Chen, W., Li, M., Lv, M., Feng, P., Hu, H., and Zhang, L. (2006). Prevention of murine experimental autoimmune encephalomyelitis by in vivo expression of a novel recombinant immunotoxin DT390-RANTES. Gene Ther 13, 1351-1359.
11. Johns, T.G., Kerlero de Rosbo, N., Menon, K.K., Abo, S., Gonzales, M.F., and Bernard, C.C. (1995). Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol 154, 5536-5541.
12. Karpus, W.J., Fife, B.T., and Kennedy, K.J. (2003). Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease. Methods 29, 362-368.
13. Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., and Iwakura, Y. (2006). IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177, 566-573.
14. Kreitman, R.J. (1999). Immunotoxins in cancer therapy. Curr Opin Immunol 11, 570-578.
15. LeMaistre, C.F., Meneghetti, C., Rosenblum, M., Reuben, J., Parker, K., Shaw, J., Deisseroth, A., Woodworth, T., and Parkinson, D.R. (1992). Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor. Blood 79, 2547-2554.
16. Liu, Y.Y., Gordienko, I., Mathias, A., Ma, S., Thompson, J., Woo, J.H., and Neville, D.M., Jr. (2000). Expression of an anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin in a mutant CHO cell line. Protein Expr Purif 19, 304-311.
17. Martin, R., and McFarland, H.F. (1995). Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 32, 121-182.
18. Nakae, S., Iwakura, Y., Suto, H., and Galli, S.J. (2007). Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 81, 1258-1268.
19. Nguyen, L.T., Atobe, K., Barichello, J.M., Ishida, T., and Kiwada, H. (2007). Complex formation with plasmid DNA increases the cytotoxicity of cationic liposomes. Biol Pharm Bull 30, 751-757.
20. Owens, T. (2003). The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage. Curr Opin Neurol 16, 259-265.
21. Park, H., Li, Z., Yang, X.O., Chang, S.H., Nurieva, R., Wang, Y.H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., and Dong, C. (2005). A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6, 1133-1141.
22. Pastan, I., Chaudhary, V., and FitzGerald, D.J. (1992). Recombinant toxins as novel therapeutic agents. Annu Rev Biochem 61, 331-354.
23. Phillips, S.M., Bhopale, M.K., Constantinescu, C.S., Ciric, B., Hilliard, B., Ventura, E., Lavi, E., Rostami, A. (2007). Effect of DAB389IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats. J Neurol Sci 263, 59-69.
24. Röhn, T.A., Jennings, G.T., Hernandez, M., Grest, P., Beck, M., Zou, Y., Kopf, M., and Bachmann, M.F. (2006). Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol 36, 2857-2867.
25. Rui, H.B., and Chen, Y.Z. (2002). Cell-specific expression of the diphtheria toxin A-chain coding sequence induces cancer cell suicide. Chin Med J 115, 869-873.
26. Stockinger, B., and Veldhoen, M. (2007). Differentiation and function of Th17 T cells. Curr Opin Immunol 19, 281-286.
27. Sun X., and Zhang, Z.R. (2004). Preparation of lipid-protamin-DNA complexes and evaluation of their transfection efficiencies in vitro. Acta Pharmaceutica Sinica 39, 792-796.
28. Thompson, J., Hu, H.Z., Scharff, J., and Neville, Jr., D.M. (1995). Anti-CD3 single-chain immunotoxin with a truncated diphtheria-toxin avoid inhibition by preexisting antibodies in human blood. J Biol Chem 270, 28037-28041.
29. Touil, T., Fitzgerald, D., Zhang, G.X., Rostami, A.M., and Gran, B. (2006). Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis. Drug News Perspect 19, 77-83.
30. Urieto, J.O., Liu, T., and Black, J.H. (2004). Expression and purification of the recombinant diphtheria fusion toxin DT388-IL3 for phase I clinical trials. Protein Expr Purif 33, 123-133.
31. Wolff, J.A., Ludtke, J.J., Acsadi, G., Williams, P., and Jani, A. (1992). Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1, 363-369.